Copyright
©The Author(s) 2025.
World J Clin Oncol. Sep 24, 2025; 16(9): 108731
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.108731
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.108731
Table 1 Summary of studies investigating mesoporous silica nanoparticles for blood-brain barrier penetration
Ref. | Design | MSN size | Cargo | Surface modifications | Transport of MSNs | Primary findings |
Chen et al[120] | Zebrafish model and cell culture | 50, 200 nm | Doxorubicin | PEG; TMAC | Protein corona-mediated transcytosis | Negatively charged (approximately -40 mV), 50 nm MSNs were shown to cross the BBB via a protein corona-mediated mechanism involving afamin, basigin, and ApoE |
Baghirov et al[122] | In vitro BBB model and in vivo mouse imaging | 50 (spherical), 300 approximately 100 nm (rod) | -- | PEG-PEI copolymer | Transcellular (transcytosis) | PEG-PEI enhanced cellular uptake, and MSNs were detectable in brain vasculature with low cytotoxicity |
Shadmani et al[125] | In vitro and in vivo | Approximately 50 nm | Methotrexate | TAT peptide | Energy-dependent endocytosis (expected) | TAT-functionalized MSNs improved methotrexate delivery, increasing the brain-to-plasma ratio |
Mo et al[38] | In vitro | 40 nm | Doxorubicin | PEI-cRGD peptide | Integrin receptor-mediated | cRGD-conjugated MSNs show enhanced BBB penetration and glioblastoma targeting |
Bouchoucha et al[121] | In vitro and in vivo | 50, 160 nm | Gd-chelate (MRI contrast agent) | PEG; Ri7 antibody; Gd chelate | Receptor-mediated (antibody) | Ri7-MSNs (50 nm) had targeted brain endothelium, were MRI-visible, and showed in vivo brain accumulation |
Shevtsov et al[110] | In vitro and in vivo (Wistar rat glioma model) | 100 to 150 nm × 250 nm (length) | Fe (0) (Core) | -- | -- | Fe-loaded MSNs accumulated in glioma and showed a dose-dependent toxicity |
Orlando et al[153] | In vitro and ex vivo | 30, 250 nm | -- | APTES modified (MSN-NH2) | Size/protein corona-dependent | MSNs showed size-dependent toxicity, with 30 nm particles being less toxic, and protein corona exerted a key role in modulating cell interactions |
Table 2 Physical properties and hemolytic activity
Ref. | Factors affecting hemolysis | Hemolysis range | Key findings |
Yu et al[137] | Size, shape, porosity | 10-500 (significant hemolysis at high doses) | Porosity and shape affected hemolysis |
Paula et al[138] | Size, pore, surface charge | -- | Protein corona and positive charge lowered hemolysis |
Joglekar et al[148] | Morphology (spherical/tubular) | Minimal up to 500 µg/mL | Spherical MSNs showed lower hemolysis |
Martínez-Carmona et al[165] | Protein interaction | EC50: 8-28 µg/mL (protein-dependent) | Protein corona suppressed hemolysis dose-dependently |
Yildirim et al[176] | Surface functionalization with ionic, polar, neutral, and hydrophobic groups | Approximately 100-500 µg/mL | Functionalization with ionic groups reduced hemolysis |
- Citation: Abdel-Maksoud YT, Abdelhaseb AH, Abdo AAE, Kamel AM, Elsebay MT, Attia MS. Responsive mesoporous silica nanocarriers in glioma therapy: A step forward in overcoming biological barriers. World J Clin Oncol 2025; 16(9): 108731
- URL: https://www.wjgnet.com/2218-4333/full/v16/i9/108731.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i9.108731